. 2008 Jul 1;83(1):2681–26829. doi: 10.1002/0471142727.mb2608s83
Copyright © 2008 John Wiley & Sons, Inc.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
Figure 4.
Commercially available 3′‐end modifications of Morpholino oligos.